3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
NET
1
Endocrine
1
Conditions
Colorectal Neoplasms
13
Stomach Neoplasms
11
Esophageal Neoplasms
8
Barrett Esophagus
6
Gastrointestinal Neoplasms
5
Rectal Neoplasms
3
Colonic Neoplasms
3
Precancerous Conditions
2
Lung Neoplasms
2
Hemorrhage
2
Gastric GIST
2
Esophageal Squamous Cell Carcinoma
2
Colonic Polyps
2
Carcinoma, Non-Small-Cell Lung
2
Adenoma
2
Adenocarcinoma Of Esophagus
2
Tobacco Use Disorder
1
Submucosal Tumor of Stomach
1
Small Size Gastrointestinal Stromal Tumors
1
Small Cell Lung Carcinoma
1
Rectal Neuroendocrine Tumors
1
Polyps
1
Pituitary Neoplasms
1
Personal Satisfaction
1
Pathological Conditions, Anatomical
1
Paranasal Sinus Neoplasms
1
Pancreatic Neoplasms
1
Oropharyngeal Neoplasms
1
Neuroendocrine Tumors
1
Neoplasms, Glandular and Epithelial
1
Interventions
lutetium Lu 177 dotatate
34
Everolimus
33
lanreotide
13
gallium Ga 68 dotatate
13
Temozolomide
13
Magnetic Resonance Spectroscopy
13
Nivolumab
12
pembrolizumab
11
Octreotide
11
Capecitabine
11
177Lu-octreotide, DOTA(0)-Tyr(3)-
10
cabozantinib
9
Positron Emission Tomography Computed Tomography
9
3-Iodobenzylguanidine
9
surufatinib
8
Sunitinib
8
Specimen Handling
7
Carboplatin
7
pasireotide
6
amino-acid, glucose, and electrolyte solution
6
90Y-octreotide, DOTA-Tyr(3)-
6
lenvatinib
5
Lutetium-177
5
Ipilimumab
5
Fluorodeoxyglucose F18
5
Etoposide
5
Cisplatin
5
Bevacizumab
5
telotristat ethyl
4
olaparib
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Neuroendocrine Tumors
×
Endoscopic Mucosal Resection
×
Clear all
NCT06121752
2024-10-15
DNET
Asian Institute of Gastroenterology, India
Phase NA
Unknown
54 enrolled